2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
about
Molecular technology and pancreatic cancer.A mammalianized synthetic nitroreductase gene for high-level expressionProdrug activation enzymes in cancer gene therapy.Novel non-operative treatment and treatment strategies in pancreatic cancer.Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.Targeted prodrug design to optimize drug delivery.Feline hyperthyroidism: advances towards novel molecular therapeutics.Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugsGene therapy and targeted toxins for glioma.Nitroreductase: a prodrug-activating enzyme for cancer gene therapy.NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazoleRadiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivoEscherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.Notch1-expressing cells are indispensable for prostatic branching morphogenesis during development and re-growth following castration and androgen replacement.DNA sense-and-respond protein modules for mammalian cells.Antibody directed enzymes revive anti-cancer prodrugs concept.Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro.Time scale of radiation damage by 2,4-dinitrophenyl-aziridine (CB 1954) in Chinese hamster cells: a rapid-mix study.Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.Cell proliferation and the action of cytotoxic agents on haemopoietic tissue.The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies.Radiosensitization by the 2,4-dinitro-5-aziridinyl benzamide CB 1954: a structure/activity study.Chemotherapeutic tumour targeting using clostridial sporesGene therapy and targeted toxins for glioma
P2860
Q31800438-0F2EDC2F-3B49-4A12-95A8-F6F72419FFD6Q33497608-8C1309E7-AF5D-459B-B14D-DF7303888B86Q33968115-ABDDC8C5-8B8D-4DB5-A6C9-30A807003C06Q34074879-6BF261CC-B97B-4E2A-BC3D-B420180E383EQ34176439-866D829F-36A8-4EBE-8BAD-A034BA555B22Q34461985-492D7F81-48B2-499E-AC66-D1C199F5B25DQ34549559-F323FE5C-5F9D-4836-9B47-B5A0490DD1D7Q34775024-32A452DF-B177-4CA4-949E-6655E6323BB4Q35027309-794A3453-7821-42D9-9680-3694E77D0472Q35118933-C8757448-601D-46E6-A47B-7A9B6E46FC1BQ35964830-7E7D3934-9F75-4F4C-9781-E21506C9F970Q35981697-ACFFACC6-4FA9-4DF6-826F-814AECACCF17Q35991362-53592252-E224-487D-9860-B4BD9A69DD8BQ40035482-685DBBA9-F424-4055-A412-32DCCED569B8Q40577146-3DFC2810-50BD-40C6-92A5-CA3537F98131Q40989999-D501A187-51F5-44D3-9005-FCC925525491Q41153114-08B6BFF2-38A5-4595-952E-96E216D54C57Q42029049-3BDE9618-DEFB-49DB-98EE-72191E049B30Q42224882-C009E19E-0A00-4E27-922B-8EAB9602B6DCQ43236564-15957FD6-109F-4BED-AA26-A9333FB9E84AQ43592769-E0782027-0D76-4A64-B030-BCC35CD2B746Q47978690-5FDAFA97-FDD4-4441-9EC9-DCC1C4A2E4A0Q52427977-E9B9F497-1172-4AC5-9C5A-B9C9D8315D6AQ56864677-CE84DF4B-A777-41A1-A9AD-1EB8F2FE4CCAQ57006162-3688D571-5A09-4F89-8DF5-26E1F984B390
P2860
2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@en
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@nl
type
label
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@en
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@nl
prefLabel
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@en
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@nl
P2093
P1476
2,4-dinitro-5-ethyleneiminoben ...... h of the Walker carcinoma 256.
@en
P2093
Connors TA
Mitchley BC
Whisson ME
P304
P356
10.1016/0006-2952(69)90267-6
P407
P577
1969-06-01T00:00:00Z